Cargando…
Carcinoid heart disease: a guide for screening and timing of surgical intervention
The cardiac manifestations of a neuroendocrine tumour are referred to as carcinoid heart disease (CaHD) and are associated with a poor prognosis. Surgical intervention is the only proven therapeutic option and may prolong survival and quality of life. No consensus has been reached internationally wi...
Autores principales: | Hart, E. A., Meijs, T. A., Meijer, R. C. A., Dreijerink, K. M., Tesselaar, M. E., de Groot, C. A., Valk, G. D., Chamuleau, S. A. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571595/ https://www.ncbi.nlm.nih.gov/pubmed/28631210 http://dx.doi.org/10.1007/s12471-017-1011-2 |
Ejemplares similares
-
European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease
por: Grozinsky‐Glasberg, Simona, et al.
Publicado: (2022) -
Elevated Serotonin and NT-proBNP Levels Predict and Detect Carcinoid Heart Disease in a Large Validation Study
por: Levy, Sonja, et al.
Publicado: (2022) -
Simultaneous surgical treatment of primary ovarian carcinoid and carcinoid heart disease
por: Andrushchuk, Uladzimir, et al.
Publicado: (2022) -
Carcinoid heart disease
por: Geller, Stephen A., et al.
Publicado: (2013) -
Surgical aspects of valve replacement in carcinoid heart disease
por: Albåge, Anders, et al.
Publicado: (2020)